Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-03-01-2003
Volume

Table of Contents

Table of Contents

External Link - article-49266.pdf

Articles in this issue
One World, Many Regulations
chart2-49268-1408721743728.jpg
Membership Has Its Privileges
chart1-49270-1408721735995.gif
The Right Staff
The Virtues of Virtual Training
Table of Contents
Executive Prophesies Vision for the Future

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Gen Li
Robert Lisicki
Related Content
Site Logo
August 6th 2025

Success Guide – How to Turn Pharma Reps into Masters of the Message

ACTO
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 6th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
Stock.adobe.com
August 6th 2025

President Trump Warns of 250% Tariffs While Industry Continues to React to MFN Order

Mike Hollan
Beyond the Prescription: Pharma's Role in Digital Health Conversations
August 6th 2025

Beyond the Prescription: Pharma's Role in Digital Health Conversations

Canopy
FDA Approves Expanded Indication for Teva’s Ajovy in Pediatric Patients with Episodic Migraine
August 6th 2025

FDA Approves Expanded Indication for Teva’s Ajovy in Pediatric Patients with Episodic Migraine

Don Tracy, Associate Editor
SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics for $412 Million
August 6th 2025

SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics for $412 Million

Don Tracy, Associate Editor